APOE and Alzheimer disease: Though it is unlikely that APOE ε4 status will have a pivotal role in the clinical diagnosis of AD, APOE ε4 assessment may be significant with the arrival of anti-Aβ DMTs, as APOE ε4 carriers have higher incidence of ARIA [71].